Skip to content

PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population

Prophylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02128997
Acronym
PROVAC
Enrollment
136
Registered
2014-05-01
Start date
2014-05-31
Completion date
2017-08-31
Last updated
2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Complication

Keywords

obesity, cesarean section, wound complication

Brief summary

This study will assess whether a negative pressure wound vacuum therapy (NPWT) on closed incisions decreases the risk of wound complications among obese patients after cesarean section All patients having a cesarean section in labor or presenting to the triage unit and requiring a cesarean section will be eligible Main study intervention: this involves the use of a negative pressure wound vacuum therapy on a closed incision.

Detailed description

Objectives To evaluate whether there is a decrease in wound complications among obese patients who are treated with closed incision NPWT versus standard post cesarean section wound care protocol. Primary outcome variable(s) The primary outcome variable is wound complications defined as any readmission for a wound issue within four weeks of discharge, infection, or wound breakdown. Secondary outcome will look at patient quality of life among those with NPWT versus usual care arm. A survey addressing pain, breast feeding questions and ability to perform activity of daily living will be administered during the inpatient stay and at the postpartum visit. Background Obesity, defined as a body mass index (BMI) 30kg/m2, continues to be a growing epidemic in the United States. According to National Center for Health Statistics Data1, almost one third of adults and 17% of youth were obese in 2009-2010. Furthermore, non-Hispanic Blacks have the age-adjusted rates of obesity (49.5%). In a study by Chu et al analyzing data from 26 states in the Pregnancy Risk Assessment Monitoring System (PRAMS) database, 20% of women who delivered were obese and in certain ethnic and insurance subgroups, the rates were as high as 33%. In 2008, according to reports by the Pennsylvania State statistics, the rates of obesity in the city of Philadelphia were as high as 64%. Multiple studies have demonstrated the increased risks for diabetes, hypertension and adverse pregnancy outcomes (APO) during pregnancy in the obese population. In addition, obesity is a well established independent risk factor for the development of a wound complication or infection after a cesarean delivery, with rates ranging from 10-15% . Certain measures such as antibiotic prophylaxis and closure of the subcutaneous space are techniques that have demonstrated a decreased incidence of wound disruption. Currently no randomized controlled trials have looked at the effects of surgical approach or choice of abdominal incision in the obese or extremely obese woman undergoing cesarean delivery. However, the few retrospective studies that have addressed this issue have demonstrated mixed results. Given the paucity of randomized controlled trials evaluating the prevention of wound complications in obese women undergoing cesarean delivery, a recent review by Tipton emphasized the necessity for such trials to evaluate methods with which to improve postoperative wound care and healing in this high risk cohort. In the past decade, negative pressure wound therapy (NPWT) has become accepted in the treatment of expediting healing of open wounds 15-18. NPWT is a method in which a vacuum device is placed on the wound in order to remove excess interstitial fluid, increase tissue vascularity, decrease bacterial colonization, and place mechanical stress on adjacent wound edges which aids in wound contractility and closure. Therefore, the positive effects of NPWT on open wounds have been well studied and established. Recent studies have been performed to assess a potential effect of NPWT on closed incisions non-obstetric fields. A recent study by Grauhan et al compared the effects of NPWT over closed sternotomy incisions in obese patients compared to conventional sterile wound dressing and noted a significant reduction in the rates of wound infection in those treated with NPWT. Another study by Vargo assessed the effects of NPWT on closed incisions in patients undergoing abdominal therapy compared to a historical control also noted a decreased wound infection rate and no evidence of skin necrosis. In contrast, a recent study by Masden et al. looked at rates of infection and dehiscence in patients with multiple comorbidities status post predominantly lower extremity wounds and did not appreciate a difference between the NPWT group and dry dressing group24. Therefore, the need for further studies assessing the benefits of NPWT on various anatomical sites has been clearly established.

Interventions

DEVICEClosed incision wound vacuum (Prevena)

wound vacuum to be placed on a closed incision

Sponsors

Kinetic Concepts, Inc.
CollaboratorINDUSTRY
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Key inclusion criteria BMI greater than or equal to 30 kg/m2 at less than or equal to 22 weeks of gestation Subject is laboring Subject is having an unplanned cesarean section Subject will have Pfannenstiel Skin Incision Subject has the ability to take a picture and email it to a secure account Subject receives prenatal care in the University of Pennsylvania health system and plans to follow up postpartum in the system Subject is greater than or equal to 18 years of age Key

Exclusion criteria

Subject cannot read or speak English Subject is not 18 years of age Subject does not have ability to send a picture by email Subject has preexisting diabetes mellitus (Type 1 or Type 2) , is using chronic steroids or immune-suppressants, OR being actively treated for a malignancy Subject is undergoing a scheduled cesarean section Subject is allergic to silver

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Wound ComplicationsFour weeks after cesarean sectionThe primary outcome variable was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening

Secondary

MeasureTime frameDescription
Pain ScoresPostpartum day 2On postoperative day 2, all patients were administered a pain scale: Rank sharp pain (0-10), 10 being worst possible sharp pain.
Tingling Pain ScoresPostpartum day 2On postoperative day 2, all patients were administered a pain scale: Rank tingling pain (0-10), 10 being worst possible tingling pain
Postpartum Length of StayUntil hospital discharge and then for 4 weeks follow up

Countries

United States

Participant flow

Participants by arm

ArmCount
Closed Incision Wound Vacuum (Prevena)
Closed incision wound vacuum (Prevena) Closed incision wound vacuum (Prevena): wound vacuum to be placed on a closed incision
67
Routine Wound Care
This arm includes patients having a cesarean section with routine wound care
69
Total136

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up611

Baseline characteristics

CharacteristicClosed Incision Wound Vacuum (Prevena)TotalRoutine Wound Care
Age, Continuous27 Years
STANDARD_DEVIATION 5
28 Years
STANDARD_DEVIATION 4
29 Years
STANDARD_DEVIATION 3
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
46 Participants91 Participants45 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
14 Participants26 Participants12 Participants
Region of Enrollment
United States
67 participants136 participants69 participants
Sex: Female, Male
Female
67 Participants136 Participants69 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 610 / 58
other
Total, other adverse events
0 / 610 / 58
serious
Total, serious adverse events
0 / 610 / 58

Outcome results

Primary

Number of Participants With Wound Complications

The primary outcome variable was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening

Time frame: Four weeks after cesarean section

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Closed Incision Wound Vacuum (Prevena)Number of Participants With Wound Complications3 Participants
Routine Wound CareNumber of Participants With Wound Complications4 Participants
Secondary

Pain Scores

On postoperative day 2, all patients were administered a pain scale: Rank sharp pain (0-10), 10 being worst possible sharp pain.

Time frame: Postpartum day 2

ArmMeasureValue (MEDIAN)
Closed Incision Wound Vacuum (Prevena)Pain Scores6 Unit on a scale
Routine Wound CarePain Scores5.5 Unit on a scale
Secondary

Postpartum Length of Stay

Time frame: Until hospital discharge and then for 4 weeks follow up

ArmMeasureValue (MEDIAN)
Closed Incision Wound Vacuum (Prevena)Postpartum Length of Stay3 days
Routine Wound CarePostpartum Length of Stay3 days
Secondary

Tingling Pain Scores

On postoperative day 2, all patients were administered a pain scale: Rank tingling pain (0-10), 10 being worst possible tingling pain

Time frame: Postpartum day 2

ArmMeasureValue (MEDIAN)
Closed Incision Wound Vacuum (Prevena)Tingling Pain Scores2 Unit on a scale
Routine Wound CareTingling Pain Scores1.5 Unit on a scale

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026